Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

L0600000

Lidocaine hydrochloride

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

Lidocaine hydrochloride monohydrate, 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide hydrochloride monohydrate, Lignocaine hydrochloride monohydrate, Xylocaine hydrochloride monohydrate

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C14H22N2O · HCl · H2O
Numero CAS:
6108-05-0
Peso molecolare:
288.81
Numero MDL:
MFCD00150329
Codice UNSPSC:
41116107
ID PubChem:
329817368
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

lidocaine

Produttore/marchio commerciale

EDQM

tecniche

HPLC: suitable
gas chromatography (GC): suitable

applicazioni

pharmaceutical (small molecule)

Formato

neat

Stringa SMILE

Cl[H].[H]O[H].CCN(CC)CC(=O)Nc1c(C)cccc1C

InChI

1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2
YECIFGHRMFEPJK-UHFFFAOYSA-N

Informazioni sul gene

human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Lidocaine hydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Azioni biochim/fisiol

Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

PHR1034

Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material

1366002

Lidocaine, United States Pharmacopeia (USP) Reference Standard

L0595000

Lidocaine, European Pharmacopoeia (EP) Reference Standard

PHR1669

Lidocaine Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1671

Lidocaine Related Compound C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1673

Lidocaine Related Compound H, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1670

Lidocaine Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1672

Lidocaine Related Compound E, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1674

Lidocaine Related Compound I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1675

Lidocaine Related Compound J, Pharmaceutical Secondary Standard; Certified Reference Material

1366080

Lidocaine Related Compound H, United States Pharmacopeia (USP) Reference Standard

1366013

Lidocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard

BP727

Lidocaine, British Pharmacopoeia (BP) Reference Standard

BP214

Lidocaine hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR1995

Lidocaine Impurity G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1994

Lidocaine Impurity F, Pharmaceutical Secondary Standard; Certified Reference Material

Pittogrammi

Skull and crossbones
GHS06

Avvertenze

Danger

Indicazioni di pericolo

H301

Classi di pericolo

Acute Tox. 3 Oral

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 9

1 of 9

Lidocaine Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1034

Lidocaine

Lidocaine Related Compound B Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1670

Lidocaine Related Compound B

Lidocaine Related Compound A Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1669

Lidocaine Related Compound A

vibrant-m

B1160000

Bupivacaine hydrochloride

Lidocaine Related Compound H Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1673

Lidocaine Related Compound H

Bupivacaine hydrochloride monohydrate analytical standard, for drug analysis

Supelco

B5274

Bupivacaine hydrochloride monohydrate

N-(2,6-Dimethylphenyl)chloroacetamide 99%

Sigma-Aldrich

194921

N-(2,6-Dimethylphenyl)chloroacetamide

Etoricoxib VETRANAL®, analytical standard

Supelco

32097

Etoricoxib

D-Glucuronic Acid Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1956

D-Glucuronic Acid

Mark C Tucci et al.
The European journal of neuroscience, 40(6), 2971-2979 (2014-06-18)
A previous analysis of the quinpirole sensitisation rat model of obsessive-compulsive disorder revealed that the behavioral phenotype of compulsive checking consists of three constitutive components - vigor of checking performance, focus on the task of checking, and satiety following a
Fang-Chi Yang et al.
Neurobiology of learning and memory, 112, 186-194 (2013-07-31)
Learning active or reactive responses to fear involves different brain circuitry. This study examined how the nuclus accumbens (NAc), dorsal hippocampus (DH) and medial prefrontal cortex (mPFC) may interact in memory processing for these two kinds of responses. Male Wistar
Shaun Mehta et al.
JAMA facial plastic surgery, 16(6), 414-418 (2014-09-12)
This study evaluates the postoperative outcomes achieved with incisionless otoplasty for the correction of prominauris. To determine whether incisionless otoplasty is a reliable and replicable technique in correcting prominauris. This study consisted of a retrospective electronic medical record review for
Bettina F Cuneo et al.
Circulation, 128(20), 2183-2191 (2013-11-13)
The electrophysiology of long QT syndrome (LQTS) in utero is virtually unstudied. Our goal here was to evaluate the efficacy of fetal magnetocardiography (fMCG) for diagnosis and prognosis of fetuses at risk of LQTS. We reviewed the pre/postnatal medical records
Paul M A Broens et al.
Diseases of the colon and rectum, 56(11), 1273-1281 (2013-10-10)
None of the current theories on fecal incontinence can explain fecal continence adequately. This study aims to evaluate the mechanism controlling fecal continence. Anal electrosensitivity, anorectal pressures, and rectal pressure volumetry tests were performed in 17 controls before and after
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.